Intramyocardial gene transfer of vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart

Electronic Journal of Biotechnology

Volumn 7, Issue 3, 2004, Pages 264-273

  Ojalvo, Ariana G ^a   Seralena, Alina ^a   Vispo, Nelson S ^a   Silva, Ricardo ^a   Gonzalez, Noel ^b   Guevara, Luis ^b   Batista, Juan F ^c   Montequin, Jose F ^d   Chaos, Nicolas ^b   González, Rafael ^b   Reima, Camilo ^b   Peña, Yamile ^c   Coca, Marcos ^c   Perera, Alejandro ^c   Vazquez, Raysa ^a   Puchades, Yaquelin ^a   Garcia Osuna, Tamara ^e   Dominguez, Heberto ^e   Reyes, Jose L ^e   Ali, Alfonso ^a   Herrera, Luis ^a   more..

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^b HOSPITAL CLINICOQUIRÚRGICO HERMANOS AMEIJEIRAS   (Cuba)

^c Ctro de Invest Clínicas   (Cuba)

^d Pathology Department   (Cuba)

^e Instituto de Investigaciones Porcinas   (Cuba)

Author keywords

Collateral development; Coronary artery disease; Gene therapy; Naked plasmid DNA; Revascularization; Therapeutic angiogenesis

Indexed keywords

BLOOD VESSELS; CARDIOVASCULAR SYSTEM; CELLS; DNA; IMAGE CODING; MEDICAL IMAGING; PATIENT TREATMENT;

ANGIOGENESIS; ENDOTHELIAL CELLS; PLASMIDS; VASCULAR ENDOTHELIAL GROWTH FACTORS (VEGF);

GENE TRANSFER;

NAKED DNA; PLASMID DNA; PLASMID VECTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 121;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; DISEASE MODEL; EQUIPMENT; FEMALE; GENE TRANSFER; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HYPOTHESIS; IMAGE ANALYSIS; NONHUMAN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SWINE; THORACOTOMY;

AMEROIDEA; ANIMALIA; SUIDAE; SUS SCROFA;

EID: 19944433855     PISSN: 07173458     EISSN: None     Source Type: Journal    
DOI: 10.2225/vol7-issue3-fulltext-12     Document Type: Article

References (35)

1. ASAHARA, T.; TSURUMI, Y.; TAKESHITA, S. and ISNER, J.M. Naked cDNA encoding secreted proteins for intra-arterial and intramuscular gene transfer. Seminars in Interventional Cardiology, September 1996, vol. 1, no. 3, p. 225-232.
2. BROGI, E.; SCHATTEMAN, G.; WU, T.; KIM, E.A.; VARTICOVSKI, L.; KEYT, B. and ISNER, J.M. Hypoxiainduced paracrine regulation of vascular endothelial growth factor receptor expression. Journal of Clinical Investigation, January 1996, vol. 97, no. 2, p. 469-476.
3. BUTTRICK, P.M.; KASS, A.; KITSIS, R.N.; KAPLAN, M.L. and LEINWAND, L.A. Behavior of genes directly injected into the rat heart in vivo. Circulation Research, January 1992, vol. 70, no. 1, p. 193-198.
4. CRYSTAL, R.G. Transfer of genes to humans: early lessons and obstacles to success. Science, October 1995, vol. 270, no. 5235, p. 404-410.
5. EPSTEIN, S.E.; FUCHS, S.; ZHOU, Y.F.; BAFFOUR, R. and KORNOWSKI, R. Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Cardiovascular Research, February 2001, vol. 49, no. 3, p. 532-542.
6. HARADA, K.; GROSSMAN, W.; FRIEDMAN, M.; EDELMAN, E.R.; PRASAD, P.V.; KEIGHLEY, C.S.; MANNING, W.J.; SELLKE, F.W. and SIMONS, M. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. Journal of Clinical Investigation, August 1994, vol. 94, no. 2, p. 623-630.
7. HARIAWALA, M.D.; HOROWITZ, J.R.; ESAKOF, D.; SHERIFF, D.D.; WALTER, D.H.; KEYT, B.; ISNER, J.M. and SYMES J.F. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. Journal of Surgical Research, June 1996, vol. 63, no. 1, p. 77-82.
8. HARVEY, B.G.; HACKETT, N.R.; EL-SAWY, T.; ROSENGART, T.K.; HIRSCHOWITZ, E.A.; LIEBERMAN, M.D.; LESSER, M.L. and CRYSTAL, R.G. Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs. Journal of Virology, August 1999, vol. 73, no. 8, p. 6729-6742.
9. HENDEL, R.C.; HENRY, T.D.; ROCHA-SINGH, K.; ISNER, J.M.; KEREIAKES, D.J.; GIORDANO, F.J.; SIMONS, M. and BONOW, R.O. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. Circulation, January 2000, vol. 101, no. 2, p. 118-121.
10. HENRY, T.D.; ROCHA-SINGH, K.; ISNER, J.M.; KEREIAKES, D.J.; GIORDANO, F.J.; SIMONS, M.; LOSORDO, D.W.; HENDEL, R.C.; BONOW, R.O.; EPPLER, S.M.; ZIONCHECK, T.F.; HOLMGREN, E.B. and MCCLUSKEY, E.R. Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. American Heart Journal, November 2001, vol. 142, no. 5, p. 872-880.
11. HENRY, T.D. Therapeutic angiogenesis. BMJ, June 1999, vol. 318, no. 7197, p. 1536-1539.
12. HOUCK, K.A.; LEUNG, D.W.; ROWLAND, A.M.; WINER, J. and FERRARA, N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. Journal of Biological Chemistry, December 1992, vol. 267, no. 36, p. 26031-26037.
13. KALKA, C.; TEHRANI, H.; LAUDENBERG, B.; VALE, P.R.; ISNER, J.M.; ASAHARA, T. and SYMES, J.F. VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease. Annals of Thoracic Surgery, September 2000, vol. 70, no. 3, p. 829-834.
14. KLONER, R.A.; DOW, J.; CHUNG, G. and KEDES, L.H. Intramyocardial injection of DNA encoding vascular endothelial growth factor in a myocardial infarction model. Journal of Thrombosis and Thrombolysis, December 2000, vol. 10, no. 3, p. 285-289.
15. LEE, L.Y.; PATEL, S.R.; HACKETT, N.R.; MACK, C.A.; POLCE, D.R.; EL-SAWY, T.; HACHAMOVITCH, R.; ZANZONICO, P.; SANBORN, T.A.; PARIKH, M.; ISOM, O.W.; CRYSTAL, R.G. and ROSENGART, T.K. Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121. Annals of Thoracic Surgery, January 2000, vol. 69, no. 1, p. 14-23.
16. LEHRMAN, S. Virus treatment questioned after gene therapy death. Nature, October 1999, vol. 401, no. 6753, p. 517-518.
17. LEUNG, D.W.; CACHIANES, G.; KUANG, W.J.; GOEDDEL, D.V. and FERRARA, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, December 1989, vol. 246, no. 4935, p. 1306-1309.
18. LIBBY, P.; SCHWARTZ, D.; BROGI, E.; TANAKA, H. and CLINTON, S.K. A cascade model for restenosis. A special case of atherosclerosis progression. Circulation, December 1992, vol. 86, 6 Suppl, p. III47-III52.
19. LOPEZ, J.J.; LAHAM, R.J.; STAMLER, A.; PEARLMAN, J.D.; BUNTING, S.; KAPLAN, A.; CARROZZA, J.P.; SELLKE, F.W. and SIMONS, M. VEGF administration in chronic myocardial ischemia in pigs. Cardiovascular Research, November 1998, vol. 40, no. 2, p. 272-281.
20. LOSORDO, D.W.; VALE, P.R.; HENDEL, R.C.; MILLIKEN, C.E.; FORTUIN, F.D.; CUMMINGS, N.; SCHATZ, R.A.; ASAHARA, T.; ISNER, J.M. and KUNTZ, R.E. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation, April 2002, vol. 105, no. 17, p. 2012-2018.
21. LOSORDO, D.W.; PICKERING, J.G.; TAKESHITA, S.; LECLERC, G.; GAL, D.; WEIR, L.; KEARNEY, M.; JEKANOWSKI, J. and ISNER, J.M. Use of the rabbit ear artery to serially assess foreign protein secretion after sitespecific arterial gene transfer in vivo. Evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene expression. Circulation, February 1994, vol. 89, no. 2, p. 785-792.
22. NABEL, G.J.; NABEL, E.G.; YANG, Z.Y.; FOX, B.A.; PLAUTZ, G.E.; GAO, X.; HUANG, L.; SHU, S.; GORDON, D. and CHANG, A.E. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proceedings of the National Academy of Sciences of the United States of America, December 1993, vol. 90, no. 23, p. 11307-11311.
23. NEUFELD, G.; COHEN, T.; GENGRINOVITCH, S. and POLTORAK, Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB Journal, January 1999, vol. 13, no. 1, p. 9-22.
24. OJALVO, A.G.; SERALENA, A.; VAZQUEZ, R.; MONTEQUIN, J.F.; VISPO, N.S.; SILVA, R.; ALDAMA, A.; PUCHADES, Y.; SORELL, L.T.; LOPEZ-SAURA, P.; ALFONSO, M.A.; SIMON, R.; ALI, A.; SEUC, A. and HERRERA, L. Therapeutic angiogenesis following intramuscular gene transfer of vascular endothelial growth factor 121 in a dog model of hindlimb ischemia. Electronic Journal of Biotechnology, [online]. 15 December 2003, vol. 6, no. 3, [cited 15 December 2003] . Available from Internet: http://www.ejbiotechnology.info/content/vol6/issue3/full/2/ index.html. ISSN 0717 3458.
25. PATEL, S.R.; LEE, L.Y.; MACK, C.A.; POLCE, D.R.; EL-SAWY, T.; HACKETT, N.R.; ILERCIL, A.; JONES, E.C.; HAHN, R.T.; ISOM, O.W.; ROSENGART, T.K. and CRYSTAL, R.G. Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121. Human Gene Therapy, May 1999, vol. 10, no. 8, p. 1331-1348.
26. PLOUET, J.; MORO, F.; BERTAGNOLLI, S.; COLDEBOEUF, N.; MAZARGUIL, H.; CLAMENS, S. and BAYARD, F. Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect. Journal of Biological Chemistry, May 1997, vol. 272, no. 20, p. 13390-13396.
27. ROSENGART, T.K.; LEE, L.Y.; PATEL, S.R.; SANBORN, T.A.; PARIKH, M.; BERGMAN, G.W.; HACHAMOVITCH, R.; SZULC, M.; KLIGFIELD, P.D.; OKIN, P.M.; HAHN, R.T.; DEVEREUX, R.B.; POST, M.R.; HACKETT, N.R.; FOSTER, T.; GRASSO, T.M.; LESSER, M.L.; ISOM, O.W. and CRYSTAL, R.G. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation, August 1999a, vol. 100, no. 5, p. 468-474.
28. ROSENGART, T.K.; LEE, L.Y.; PATEL, S.R.; KLIGFIELD, P.D.; OKIN, P.M.; HACKETT, N.R.; ISOM, O.W. and CRYSTAL, R.G. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. Annals of Surgery, October 1999b, vol. 230, no. 4, p. 466-470.
29. SCHWARZ, E.R.; SPEAKMAN, M.T.; PATTERSON, M.; HALE, S.S.; ISNER, J.M.; KEDES, L.H. and KLONER, R.A. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat-angiogenesis and angioma formation. Journal of the American College of Cardiology, April 2000, vol. 35, no. 5, p. 1323-1330.
30. SYMES, J.F.; LOSORDO, D.W.; VALE, P.R.; LATHI, K.G.; ESAKOF, D.D.; MAYSKIY, M. and ISNER, J.M. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Annals of Thoracic Surgery, September 1999, vol. 68, no. 3, p. 830-836.
31. TAKESHITA, S.; ISSHIKI, T. and SATO, T. Increased expression of direct gene transfer into skeletal muscles observed after acute ischemic injury in rats. Laboratory Investigation, June 1996a, vol. 74, no. 6, p. 1061-1065.
32. TAKESHITA, S.; TSURUMI, Y.; COUFFINAHL, T.; ASAHARA, T.; BAUTERS, C.; SYMES, J.; FERRARA, N. and ISNER, J.M. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Laboratory Investigation, October 1996b, vol. 75, no. 4, p. 487-501.
33. TIO, R.A.; TKEBUCHAVA, T.; SCHEUERMANN, T.H.; LEBHERZ, C.; MAGNER, M.; KEARNY, M.; ESAKOF, D.D.; ISNER, J.M. and SYMES, J.F. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium. Human Gene Therapy, December 1999, vol. 10, no. 18, p. 2953-2960.
34. VALE, P.R.; LOSORDO, D.W.; MILLIKEN, C.E.; MCDONALD, M.C.; GRAVELIN, L.M.; CURRY, C.M.; ESAKOF, D.D.; MAYSKY, M.; SYMES, J.F. and ISNER, J.M. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation, May 2001, vol. 103, no. 17, p. 2138-2143.
35. VALE, P.R.; LOSORDO, D.W.; MILLIKEN, C.E.; MAYSKY, M.; ESAKOF, D.D.; SYMES, J.F. and ISNER, J.M. Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation, August 2000, vol. 102, no. 9, p. 965-974.